Comparative efficacy and safety of oral azithromycin versus doxycycline in moderate-to-severe Acne vulgaris: a systematic review and meta-analysis [0.03%]
口服阿奇霉素与多西环素治疗中重度寻常痤疮疗效和安全性的比较：系统性回顾及荟萃分析
Asia Batool,Muhammad Sharjeel Abbas,Makhzan Ali Akbar et al.
Asia Batool et al.
Background: Acne vulgaris is a chronic inflammatory disease and is one of the leading causes of dermatological morbidities among young adults. Doxycycline is widely recommended as first-line therapy for moderate to severe...
A safety checklist before initiating second-generation immunomodulating drugs for inflammatory dermatoses: a systematic review [0.03%]
第二代免疫调节药物治疗炎症性皮肤病启动前的安全性评估检查清单：系统评价
Stine R Haysen,Lykke Skaarup,Simon Poulsen et al.
Stine R Haysen et al.
Background/aim: Second-generation immunomodulating drugs for inflammatory dermatoses have expanded over the past decades. Contraindications and special warnings must be considered before starting any treatment, but identi...
Efficacy and safety of combining microneedling with oral doxycycline for the treatment of rosacea: a retrospective comparative cohort study [0.03%]
微针治疗结合口服多西环素治疗玫瑰痤疮的疗效和安全性：回顾性队列研究
Kuanyu Xia,Yiran Peng,Zixi Jiang et al.
Kuanyu Xia et al.
Purpose/aim of the study: Oral doxycycline (DOX) is a first-line systemic therapy for rosacea; however, persistent vascular features, such as fixed erythema and flushing, and neurosensory symptoms, such as burning, may re...
A powerful way to improve psoriasis: the Mediterranean diet intervention of the MEDIPSO study [0.03%]
MEDIPSO研究的地中海饮食干预改善银屑病的有效方法
Pauline V Do,Omar Raheel,Steven R Feldman
Pauline V Do
Eliza J Dewey,Steven R Feldman
Eliza J Dewey
Efficacy of polyphenolic compounds for hair regeneration: a systematic review and meta-analysis of randomized controlled trials [0.03%]
黄酮类化合物生发疗效的系统评价和meta分析
Chaimae El Ammari,Ana María García-Muñoz,Rubén Zapata-Pérez et al.
Chaimae El Ammari et al.
Background: Non-scarring alopecia, including androgenetic alopecia, alopecia areata, and telogen effluvium, is highly prevalent and often associated with significant psychosocial burden. Although treatments such as minoxi...
Intralesional secukinumab for localized, recalcitrant hidradenitis suppurativa: a case series of rapid symptom relief [0.03%]
司库奇尤单抗瘤内注射治疗局限性、难治性汗腺炎的病例报告：快速改善症状的有效疗法
Junyou Zheng,Dong Luo,Ke Zhang et al.
Junyou Zheng et al.
Purpose: Hidradenitis suppurativa (HS) is a debilitating, chronic, inflammatory disease. While secukinumab (an IL-17A inhibitor) demonstrates systemic efficacy, specific lesions often remain resistant to systemic therapy,...
Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial [0.03%]
富血小板血浆、可注射富血小板纤维蛋白及生长因子 concentrate 对女性型脱发疗效和安全性的比较：一项前瞻性多中心随机临床试验
Man Li,Yue Bai,Zhenzhen Ye et al.
Man Li et al.
Background: Comparative studies among different autologous platelet concentrate types for FPHL remain lacking. Methods: Patients with F...
Randomized Controlled Trial
The Journal of dermatological treatment. 2026 Dec;37(1):2659498. DOI:10.1080/09546634.2026.2659498 2026
Influence of disease control and perceived risk on atopic dermatitis treatment decisions [0.03%]
疾病控制和感知风险对特应性皮炎治疗决策的影响
Allison R Loiselle,Jessica K Johnson,Wendy Smith Begolka
Allison R Loiselle
Objective: Patients with atopic dermatitis (AD) face an increasingly complex treatment landscape with prescription options that vary in efficacy, safety, and mode of administration. The aim of this study was to evaluate h...
Modulation of mu-opioid pathway for the treatment of pruritus: a systematic review of 1,146 patients [0.03%]
μ-阿片类途径调节治疗瘙痒的系统评价：1146例患者的研究
Khalid M A Ahmed,Amro Abu Suleiman,Alaa I Alnajdawi et al.
Khalid M A Ahmed et al.
Background: Pruritus is a debilitating symptom and conventional therapies often provide incomplete relief. The μ-opioid receptor (MOR) pathway is a key regulator of itch, and μ-pathway-modulating agents are increasingly...